- Home
- AIN vs RXRX Comparison
AIN vs RXRX Comparison
Compare AIN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIN
- RXRX
- Stock Information
- Founded
- AIN 1895
- RXRX 2013
- Country
- AIN United States
- RXRX United States
- Employees
- AIN N/A
- RXRX N/A
- Industry
- AIN Textiles
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- AIN Consumer Discretionary
- RXRX Health Care
- Exchange
- AIN Nasdaq
- RXRX Nasdaq
- Market Cap
- AIN 2.5B
- RXRX 2.6B
- IPO Year
- AIN 1987
- RXRX 2021
- Fundamental
- Price
- AIN $68.99
- RXRX $5.29
- Analyst Decision
- AIN Buy
- RXRX Buy
- Analyst Count
- AIN 5
- RXRX 4
- Target Price
- AIN $82.00
- RXRX $8.25
- AVG Volume (30 Days)
- AIN 309.2K
- RXRX 17.5M
- Earning Date
- AIN 04-28-2025
- RXRX 05-08-2025
- Dividend Yield
- AIN 1.56%
- RXRX N/A
- EPS Growth
- AIN N/A
- RXRX N/A
- EPS
- AIN 2.80
- RXRX N/A
- Revenue
- AIN $1,230,615,000.00
- RXRX $58,839,000.00
- Revenue This Year
- AIN $3.61
- RXRX $64.84
- Revenue Next Year
- AIN $2.67
- RXRX $55.98
- P/E Ratio
- AIN $24.79
- RXRX N/A
- Revenue Growth
- AIN 7.21
- RXRX 32.00
- 52 Week Low
- AIN $67.39
- RXRX $5.19
- 52 Week High
- AIN $95.47
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- AIN 34.36
- RXRX 33.28
- Support Level
- AIN $70.49
- RXRX $6.27
- Resistance Level
- AIN $74.16
- RXRX $6.94
- Average True Range (ATR)
- AIN 1.91
- RXRX 0.38
- MACD
- AIN -0.18
- RXRX -0.06
- Stochastic Oscillator
- AIN 18.49
- RXRX 5.71
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.